目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Techniques
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Impact on Supply Chain
5.3.3. Regional Impact
5.3.4. Opportunity and Threat Analysis

6. GLOBAL REAL-TIME PCR (QPCR) MARKET, BY PRODUCT
6.1. Overview
6.2. Reagents & Consumables
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
6.3. Instruments
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
6.4. Software & Services
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027

7. GLOBAL REAL-TIME PCR (QPCR) MARKET, BY APPLICATION
7.1. Overview
7.2. Clinical
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
7.3. Research
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
7.4. Forensics
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
7.5. Others
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027

8. GLOBAL REAL-TIME PCR (QPCR) MARKET, BY END USER
8.1. Overview
8.2. Hospitals and Diagnostic Centers
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
8.3. Research Laboratories and Academic Institutes
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
8.4. Pharmaceutical and Biotechnology Companies
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027
8.5. Others
Market Estimates & Forecast, by Region, 2018-2027
Market Estimates & Forecast, by Country, 2018-2027

9. GLOBAL REAL-TIME PCR (QPCR) MARKET, BY REGION
9.1. Overview
9.2. North America
9.2.1. US
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. Italy
9.3.4. Spain
9.3.5. UK
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Rest of the World
9.5.1. Middle East
9.5.2. Africa
9.5.3. Latin America

10. COMPANY LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Real-Time PCR (qPCR) Market
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Real-Time PCR (qPCR) Market
10.7. Key Developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger &Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income,2020
10.8.2. Major Players R&D Expenditure,2020

11. COMPANY PROFILES
11.1. ABL SA Group
11.1.1. Company Overview
11.1.2. Products Offered
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Agilent Technologies Inc
11.2.1. Company Overview
11.2.2. Products Offered
11.2.3. Financial Overview
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Analytik Jena AG
11.3.1. Company Overview
11.3.2. Products Offered
11.3.3. Financial Overview
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. BD
11.4.1. Company Overview
11.4.2. Products Offered
11.4.3. Financial Overview
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Bio-Rad Laboratories
11.5.1. Company Overview
11.5.2. Products Offered
11.5.3. Financial Overview
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. F-Hoffman-La Roche Ltd.
11.6.1. Company Overview
11.6.2. Products Offered
11.6.3. Financial Overview
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Fluidigm Corporation
11.7.1. Company Overview
11.7.2. Products Offered
11.7.3. Financial Overview
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Lumex Instruments
11.8.1. Company Overview
11.8.2. Products Offered
11.8.3. Financial Overview
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Primerdesign Ltd.
11.9.1. Company Overview
11.9.2. Products Offered
11.9.3. Financial Overview
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Qiagen
11.10.1. Company Overview
11.10.2. Products Offered
11.10.3. Financial Overview
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. ThermoFisher Scientific
11.11.1. Company Overview
11.11.2. Products Offered
11.11.3. Financial Overview
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
11.12. Takara Bio Inc.
11.12.1. Company Overview
11.12.2. Products Offered
11.12.3. Financial Overview
11.12.4. Key Developments
11.12.5. SWOT Analysis
11.12.6. Key Strategies
11.13. Toyobo Inc.
11.13.1. Company Overview
11.13.2. Products Offered
11.13.3. Financial Overview
11.13.4. Key Developments
11.13.5. SWOT Analysis
11.13.6. Key Strategies
11.14. Vela Diagnostics
11.14.1. Company Overview
11.14.2. Products Offered
11.14.3. Financial Overview
11.14.4. Key Developments
11.14.5. SWOT Analysis
11.14.6. Key Strategies

12. APPENDIX
12.1. References
12.2. Related Reports
?

LIST OF TABLES
TABLE 1 GLOBAL REAL-TIME PCR (QPCR) MARKET SYNOPSIS, 2018-2027
TABLE 2 GLOBAL REAL-TIME PCR (QPCR)MARKET ESTIMATES &FORECAST, 2018-2027 (USD MILLION)
TABLE 3 GLOBAL REAL-TIME PCR (QPCR) MARKET, BYPRODUCT, 2018-2027 (USD MILLION)
TABLE 4 GLOBAL REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 5 NORTH AMERICA: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 6 NORTH AMERICA REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 7 US: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 8 US REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 9 CANADA: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 10 CANADA REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 11 EUROPE: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 12 EUROPE: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 13 GERMANY: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 14 GERMANY: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 15 UK: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 16 UK: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 17 FRANCE: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 18 FRANCE: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 19 ITALY: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 20 ITALY: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 21 SPAIN: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 22 SPAIN: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 23 REST OF EUROPE: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 24 REST OF EUROPE: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 25 ASIA-PACIFIC: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 26 ASIA-PACIFIC: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION,2018-2027 (USD MILLION)
TABLE 27 INDIA: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 28 INDIA: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 29 CHINA: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 30 CHINA: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 31 JAPAN: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 32 JAPAN: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 33 AUSTRALIA: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 34 AUSTRALIA: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 35 SOUTH KOREA: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 36 SOUTH KOREA: REAL-TIME PCR (QPCR) MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 37 REST OF ASIA-PACIFIC: REAL-TIME PCR (QPCR)MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 38 REST OF ASIA-PACIFIC: REAL-TIME PCR (QPCR)MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 39 REST OF THE WORLD: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 40 REST OF THE WORLD: REAL-TIME PCR (QPCR)MARKET, APPLICATION, 2018-2027 (USD MILLION)
TABLE 41 MIDDLE EAST: REAL-TIME PCR (QPCR) MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 42 MIDDLE EAST: REAL-TIME PCR (QPCR)MARKET, APPLICATION, 2018-2027 (USD MILLION)
TABLE 43 AFRICA: REAL-TIME PCR (QPCR)MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 44 AFRICA: REAL-TIME PCR (QPCR)MARKET, APPLICATION,2018-2027 (USD MILLION)
TABLE 45 LATIN AMERICA: REAL-TIME PCR (QPCR)MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 46 LATIN AMERICA: REAL-TIME PCR (QPCR)MARKET, APPLICATION, 2018-2027 (USD MILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL REAL-TIME PCR (QPCR) MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL REAL-TIME PCR (QPCR) MARKET
FIGURE 4 GLOBAL REAL-TIME PCR (QPCR) MARKET SHARE, BY PRODUCT, 2020(%)
FIGURE 5 GLOBAL REAL-TIME PCR (QPCR)MARKET SHARE, BY APPLICATION, 2020(%)
FIGURE 6 GLOBAL REAL-TIME PCR (QPCR) MARKET SHARE, BY REGION, 2020(%)
FIGURE 7 NORTH AMERICA: REAL-TIME PCR (QPCR)MARKET SHARE, BY REGION, 2020 (%)
FIGURE 8 EUROPE: REAL-TIME PCR (QPCR) MARKET SHARE, BY REGION, 2020(%)
FIGURE 9 ASIA-PACIFIC: REAL-TIME PCR (QPCR) MARKET SHARE, BY REGION, 2020(%)
FIGURE 10 REST OF THE WORLD: REAL-TIME PCR (QPCR) MARKET SHARE, BY REGION, 2020(%)
FIGURE 11 GLOBAL REAL-TIME PCR (QPCR) MARKET: COMPANY SHARE ANALYSIS, 2020(%)
FIGURE 12 ABL SA GROUP: KEY FINANCIALS
FIGURE 13 ABL SA GROUP: SWOT ANALYSIS
FIGURE 14 AGILENT TECHNOLOGIES, INC: KEY FINANCIALS
FIGURE 15 AGILENT TECHNOLOGIES, INC:SWOT ANALYSIS
FIGURE 16 ANALYTIK JENA AG: KEY FINANCIALS
FIGURE 17 ANALYTIK JENA AG: SWOT ANALYSIS
FIGURE 18 BD: KEY FINANCIALS
FIGURE 19 BD: SWOT ANALYSIS
FIGURE 20 BIO-RAD LABORATORIES, INC.: KEY FINANCIALS
FIGURE 21 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS
FIGURE 22 F. HOFFMANN-LA ROCHE LTD: KEY FINANCIALS
FIGURE 23 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS
FIGURE 24 FLUIDIGM CORPORATION: KEY FINANCIALS
FIGURE 25 FLUIDIGM CORPORATIONSWOT ANALYSIS
FIGURE 26 LUMEX INSTRUMENTS: KEY FINANCIALS
FIGURE 27 LUMEX INSTRUMENTS: SWOT ANALYSIS
FIGURE 28 PRIMERDESIGN LTD: KEY FINANCIALS
FIGURE 29 PRIMERDESIGN LTD: SWOT ANALYSIS
FIGURE 30 QIAGEN: KEY FINANCIALS
FIGURE 31 QIAGEN: SWOT ANALYSIS
FIGURE 32 TAKARA BIO INC: KEY FINANCIALS
FIGURE 33 TAKARA BIO INC: SWOT ANALYSIS
FIGURE 34 THERMO FISHER SCIENTIFIC: KEY FINANCIALS
FIGURE 35 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS
FIGURE 36 TOYOBO INC: KEY FINANCIALS
FIGURE 37 TOYOBO INC: SWOT ANALYSIS
FIGURE 38 VELA DIAGNOSTICS: KEY FINANCIALS
FIGURE 39 VELA DIAGNOSTICS: SWOT ANALYSIS